Prognostic importance of expression of the Wilms’ tumor 1 gene in newly diagnosed acute promyelocytic leukemia-Reference-Cited by-同舟云学术

Prognostic importance of expression of the Wilms’ tumor 1 gene in newly diagnosed acute promyelocytic leukemia

Published:2015-01-21 Issue:8 Volume:56 Page:2289-2295
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Hecht Anna,Nolte Florian,Nowak Daniel,Nowak Verena,Reinwald Mark,Hanfstein Benjamin,Faldum Andreas,Büchner Thomas,Spiekermann Karsten,Sauerland Cristina,Weiss Christel,Hofmann Wolf-Karsten,Lengfelder Eva

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.990011

Reference28 articles.

1. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience

2. Acute promyelocytic leukemia: from highly fatal to highly curable

3. High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG

4. Presenting White Blood Cell Count and Kinetics of Molecular Remission Predict Prognosis in Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid: Result of the Randomized MRC Trial

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic and Epigenetic Signatures in Acute Promyelocytic Leukemia Treatment and Molecular Remission;Frontiers in Genetics;2022-04-12

2. The influence of Wilms' tumor 1 gene expression level on prognosis and risk stratification of acute promyelocytic leukemia patients;International Journal of Laboratory Hematology;2019-12-12

3. Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia;Blood;2019-07-10

4. Prognostic Factors in APL;Acute Promyelocytic Leukemia;2018

5. Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens;Clinical Lymphoma Myeloma and Leukemia;2017-12